Reyes v. Bertocchi

92 A.D.2d 863, 459 N.Y.S.2d 834, 35 U.C.C. Rep. Serv. (West) 1533, 1983 N.Y. App. Div. LEXIS 17238
CourtAppellate Division of the Supreme Court of the State of New York
DecidedMarch 7, 1983
StatusPublished
Cited by11 cases

This text of 92 A.D.2d 863 (Reyes v. Bertocchi) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Reyes v. Bertocchi, 92 A.D.2d 863, 459 N.Y.S.2d 834, 35 U.C.C. Rep. Serv. (West) 1533, 1983 N.Y. App. Div. LEXIS 17238 (N.Y. Ct. App. 1983).

Opinion

— In an action to recover damages for personal injuries, etc., based on medical malpractice, breach of warranty and strict products liability, defendant Bertocchi appeals from an order of the Supreme Court, Kings County (Greenstein, J.), dated October 19, 1981, which denied his motion for summary judgment dismissing the complaint as to him based upon the affirmative defense of the Statute of Limitations asserted in his answer, “without prejudice to defendant [Bertocchi] to assert and prove his affirmative defense.” Order modified, on the law, by adding after the last word of the last paragraph thereof, the following: “except that the motion to dismiss is granted with respect to the cause of action alleging a breach of warranty, and that cause of action is dismissed as to defendant Bertocchi.” As so modified, order affirmed, without costs or disbursements. In July, 1979, the female plaintiff and her husband commenced this action against her former physician, defendant Bertocchi, to recover damages resulting from the insertion into the female plaintiff of a “Majzlin Spring” intrauterine device (hereinafter IUD) in 1973. Plaintiffs also joined both the developer and the distributor of the IUD as [864]*864party defendants in the action. With respect to defendant Bertocchi, the plaintiffs’ complaint alleged, inter alla, that he committed an act of malpractice when he inserted the IUD in December, 1973. In this regard, plaintiffs alleged that Bertocchi had inserted a type of IUD which he knew or should have known (based on available medical literature and a prior warning issued by the Federal Food and Drug Administration) had the potential of causing “multiple” and “significant” complications, “including infection, disease, cramps, bleeding [and] uterus perforation” the longer it was left in the body. Plaintiffs further alleged that “for a fee” Bertocchi “provided” the IUD and that Bertocchi committed “a breach of both express and implied warranty” with regard to the IUD. Finally, with respect to Bertocchi, plaintiffs pleaded a cause of action in strict products liability by stating that “defendants herein, without determining the adverse affects [sic, effects] and the damage that could and would be done to females using said intrauterine device * * * were instrumental in placing upon the market a dangerous, unsafe improper birth control device”. In his answer, Bertocchi interposed an affirmative defense which alleged that the action “was instituted more than three (3) years after the cause of action alleged in the complaint accrued and is therefore barred by the Statute of Limitations.” Thereafter defendant Bertocchi moved, in effect, for summary judgment dismissing the complaint as time barred. His counsel argued that the “alleged malpractice, if any, occurred at the time of the insertion of the Majzlin Spring into the body of the plaintiff”, and that the action was untimely since it was instituted more than three years after the insertion of the IUD. Thereafter, Special Term denied Bertocchi’s motion without prejudice to assert and prove the Statute of Limitations defense at trial. It has been consistently held that negligence actions, including those based on malpractice, and causes of actions based on strict products liability, accrue, for the purposes of the Statute of Limitations, at the time of injury CComstock v Wilson, 257 NY 231, 235; Victorson vBock Laundry Mach. Co., 37 NY2d 395). The issue to be decided, then, is when did the injury occur: at the time of insertion, at the time symptoms began to develop, at the time that plaintiff discovered her malady, or at some other time? Defendant Bertocchi argues that the injury, if any, occurred at the time of insertion. He relies on a series of cases in which the courts have held that with respect to tort actions resulting from the inhalation and injection of chemicals and drugs, the injury is deemed to have occurred at the moment that the drug or chemical is introduced into the body and “not when the alleged deleterious effects of its component chemicals became apparent” (Thornton v Roosevelt Hosp., 47 NY2d 780, 781; see, also, Schmidt v Merchants Desp. Trans. Co., 270 NY 287; Schwartz v Heyden Newport Chem. Corp., 12 NY2d 212, cert den 374 US 808; Matter of Steinhardt v McKee, 54 NY2d 1008). In Lindsey v Robins Co. (91 AD2d 150), a strict products liability cause of action was asserted by a female plaintiff against A. H. Robins Company, Inc., the manufacturer of an IUD. The IUD in Lindsey was inserted on March 29,1971, and the plaintiff experienced no problems by reason of its presence until March, 1973. At that time] plaintiff developed a pelvic infection. In her action, commenced in February, 1976, the plaintiff in Lindsey claimed that the pelvic infection and resulting damages were caused by the fact that the IUD was defectively designed and/or manufactured. The manufacturer in Lindsey moved to dismiss the action on the ground that it was barred by the applicable three-year Statute of Limitations since the cause of action accrued in 1971, i.e., at the time of the insertion of the IUD. Special Term in Lindsey framed the issue in the following terms (p 153): “ ‘The question * * * is whether the Statute of Limitations began to run on the day the allegedly defective “Daikon Shield” intrauterine device was inserted into [865]*865plaintiff Joyce Lindsey or whether the limitation of time should be measured from the onset of the injury claimed, in this case a pelvic infection.’ ” Special Term in Lindsey went on to hold for defendants and dismissed the complaint as time barred on the ground that Thornton v Roosevelt Hosp. (47 NY2d 780, supra) was controlling and that there was “ ‘little qualitative difference between the injection of a hazardous radioactive dye, as in Thornton, and the introduction into the body of the allegedly defective contraceptive device’ ” (Lindsey v Robins Co., supra, p 153). In reversing Special Term and denying defendant Robins’ motion to dismiss, this court in Lindsey held that the rationale underlying the inhalation-injection cases, viz., that the harmful substance taken into the body by inhalation or injection acts immediately upon the body and causes injury immediately, did not apply to an IUD under the circumstances of that case. Specifically, this court in Lindsey stated (pp 157-160): “But, that assumption is not valid or applicable to the facts of the case before us. It cannot be said that there was injury at the time of the insertion of the shield because there is no basis in reason or in the record before us upon which to predicate an assumption that any infection or disease process began immediately upon insertion of the shield. Unlike the harmful dust and chemical compounds, which were harmful in their very nature, i.e., they were the ‘beasts themselves’, the shield was not, in and of itself, harmful. The ‘beasts’ were the bacteria that availed themselves of the ‘open highway’ created by the shield. It is true that the alleged design defect upon which plaintiffs based their claim against Robins was present upon implantation. Nevertheless, it is only when (and if) infectious bacteria choose to follow the ‘open highway’ — the alleged defect in the device — created by the braided string that the shield can be characterized as having become a harmful device. Up to that point in time it was only potentially harmful.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Iida v. Allied Signal, Inc.
854 F. Supp. 702 (D. Hawaii, 1994)
In Re Hawaii Federal Asbestos Cases
854 F. Supp. 702 (D. Hawaii, 1994)
Colarossi v. Schmid Laboratories, Inc.
830 F. Supp. 230 (D. New Jersey, 1993)
Couser v. Rockwell International, Inc.
142 Misc. 2d 321 (New York Supreme Court, 1989)
Goldsmith v. Howmedica, Inc.
491 N.E.2d 1097 (New York Court of Appeals, 1986)
Taddeucci v. Weitzner
130 Misc. 2d 853 (New York Supreme Court, 1986)
Goldsmith v. Howmedica, Inc.
111 A.D.2d 680 (Appellate Division of the Supreme Court of New York, 1985)
Fitzpatrick v. A. H. Robins Co.
99 A.D.2d 478 (Appellate Division of the Supreme Court of New York, 1984)
Fleishman v. Eli Lilly & Co.
96 A.D.2d 825 (Appellate Division of the Supreme Court of New York, 1983)
Manno v. Levi
94 A.D.2d 556 (Appellate Division of the Supreme Court of New York, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
92 A.D.2d 863, 459 N.Y.S.2d 834, 35 U.C.C. Rep. Serv. (West) 1533, 1983 N.Y. App. Div. LEXIS 17238, Counsel Stack Legal Research, https://law.counselstack.com/opinion/reyes-v-bertocchi-nyappdiv-1983.